Search results
Results from the WOW.Com Content Network
Infection rates dropped and stabilised throughout 2022 and 2023, leading to the end of COVID-19's classification as a severe transmissible disease in June 2023. [22] Although the pandemic has heavily disrupted the country's economy, [23] Vietnam's GDP growth rate has remained one of the highest in Asia-Pacific, at 2.91% in 2020. Due to the more ...
A police car in Hanoi with COVID-19 public health messaging. The Vietnamese government using social media platforms to keep the public informed of COVID-19 news and instructions. Thong Tin Chinh Phu (Governmental Information), the government's official Facebook page, provides nearly hourly updates on the country's pandemic situation. Zalo, a ...
The Việt Á scandal was a bribery and corruption scandal that arose during the COVID-19 pandemic in Vietnam. In 2020 and 2021, Việt Á Technology Corporation [ vi ] bribed Vietnamese government officials to sell COVID-19 RT-PCR tests , at a heavy mark-up to provincial health departments and hospitals.
The principal for obstetric management of COVID-19 include rapid detection, isolation, and testing, profound preventive measures, regular monitoring of fetus as well as of uterine contractions, peculiar case-to-case delivery planning based on severity of symptoms, and appropriate post-natal measures for preventing infection.
As the Head of the COVID-19 National Steering Committee, he was dubbed the "Commander-in-chief" in Vietnam's response to the pandemic alongside Nguyễn Xuân Phúc. [3] Thanks to the nationwide vaccination strategy , Vietnam reopened its economy and registered positive GDP growth for 2021 before breaking a record high rate in 2022. [ 4 ]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Special pages; Help; Learn to edit; Community portal; Recent changes; Upload file
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
The phase III study is the adaptive, multicenter, randomized, double-blind, placebo control study to evaluate the safety, immunogenicity, and efficacy of the Nanocovax vaccine against COVID-19 in volunteer subjects 18 years of age and older. [17]